[ALERTE] Les SCIENTIFIQUES attaquent PFIZER et REDPILLENT

c'est désormais OFFICIEL et c'est une BOMBE

Edito de l'éditeur senior Peter Doshi dans le BMJ (une des plus vieilles revues médicales du monde pour les descos) : https://www.bmj.com/content/376/bmj.o102

Ça chauffe, ils demandent les data à Pfizerpour les ignorants Pfizer a donné les conclusions de ses études internes mais pas les données brutes donc aucun moyen de vérifier si tout ça colle ou si y'a une couille on est littéralement sur du "fais moi confiance wallah"et dans l'article ils comparent ça avec le scandale du Tamiflu ayaaaao

• In the pages of The BMJ a decade ago, in the middle of a different pandemic, it came to light that governments around the world had spent billions stockpiling antivirals for influenza that had not been shown to reduce the risk of complications, hospital admissions, or death. The majority of trials that underpinned regulatory approval and government stockpiling of oseltamivir (Tamiflu) were sponsored by the manufacturer; most were unpublished, those that were published were ghostwritten by writers paid by the manufacturer, the people listed as principal authors lacked access to the raw data, and academics who requested access to the data for independent analysis were denied.1234
  The Tamiflu saga heralded a decade of unprecedented attention to the importance of sharing clinical trial data.56 Public battles for drug company data,78 transparency campaigns with thousands of signatures,910 strengthened journal data sharing requirements,1112 explicit commitments from companies to share data,13 new data access website portals,8 and landmark transparency policies from medicines regulators1415 all promised a new era in data transparency.
  Progress was made, but clearly not enough. The errors of the last pandemic are being repeated. Memories are short. Today, despite the global rollout of covid-19 vaccines and treatments, the anonymised participant level data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public—and are likely to remain that way for years to come.16 This is morally indefensible for all trials, but especially for those involving major public health interventions.

Ils mettent clairement en cause Pfizer et les autres pour ne pas diffuser leurs données :

• Unacceptable delay
  Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data.17 And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date, which is listed on ClinicalTrials.gov as 15 May 2023 (NCT04368728).
  The lack of access to data is consistent across vaccine manufacturers.16 Moderna says data “may be available … with publication of the final study results in 2022.”18 Datasets will be available “upon request and subject to review once the trial is complete,” which has an estimated primary completion date of 27 October 2022 (NCT04470427).
  As of 31 December 2021, AstraZeneca may be ready to entertain requests for data from several of its large phase III trials.19 But actually obtaining data could be slow going. As its website explains, “timelines vary per request and can take up to a year upon full submission of the request.”20
  Underlying data for covid-19 therapeutics are similarly hard to find. Published reports of Regeneron’s phase III trial of its monoclonal antibody therapy REGEN-COV flatly state that participant level data will not be made available to others.21 Should the drug be approved (and not just emergency authorised), sharing “will be considered.” For remdesivir, the US National Institutes of Health, which funded the trial, created a new portal to share data ( https://accessclinicaldata.niaid.nih.gov/), but the dataset on offer is limited. An accompanying document explains: “The longitudinal data set only contains a small subset of the protocol and statistical analysis plan objectives.”
  We are left with publications but no access to the underlying data on reasonable request. This is worrying for trial participants, researchers, clinicians, journal editors, policy makers, and the public. The journals that have published these primary studies may argue that they faced an awkward dilemma, caught between making the summary findings available quickly and upholding the best ethical values that support timely access to underlying data. In our view, there is no dilemma; the anonymised individual participant data from clinical trials must be made available for independent scrutiny.
  (...)

Ils remettent même en cause les politiques vaccinales et rappellent le dossier criminel de Pfizer ahiiii cette redpill :

• Transparency and trust
  As well as access to the underlying data, transparent decision making is essential. Regulators and public health bodies could release details27 such as why vaccine trials were not designed to test efficacy against infection and spread of SARS-CoV-2.28 Had regulators insisted on this outcome, countries would have learnt sooner about the effect of vaccines on transmission and been able to plan accordingly.29
  Big pharma is the least trusted industry.30 At least three of the many companies making covid-19 vaccines have past criminal and civil settlements costing them billions of dollars.31 One pleaded guilty to fraud.31 Other companies have no pre-covid track record. Now the covid pandemic has minted many new pharma billionaires, and vaccine manufacturers have reported tens of billions in revenue.32
  The BMJ supports vaccination policies based on sound evidence. As the global vaccine rollout continues, it cannot be justifiable or in the best interests of patients and the public that we are left to just trust “in the system,” with the distant hope that the underlying data may become available for independent scrutiny at some point in the future. The same applies to treatments for covid-19. Transparency is the key to building trust and an important route to answering people’s legitimate questions about the efficacy and safety of vaccines and treatments and the clinical and public health policies established for their use.

Ils disent que c'est le peuple qui a payé leurs vaccins et que les gens ont donc le droit de savoir ce qu'il en retourne :

• Twelve years ago we called for the immediate release of raw data from clinical trials.1 We reiterate that call now. Data must be available when trial results are announced, published, or used to justify regulatory decisions. There is no place for wholesale exemptions from good practice during a pandemic. The public has paid for covid-19 vaccines through vast public funding of research, and it is the public that takes on the balance of benefits and harms that accompany vaccination. The public, therefore, has a right and entitlement to those data, as well as to the interrogation of those data by experts.

Le dernier paragraphe est littéralement une gifle :

• Pharmaceutical companies are reaping vast profits without adequate independent scrutiny of their scientific claims.33 The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations. We need complete data transparency for all studies, we need it in the public interest, and we need it now.

J'espère que ces scientifiques ne sont pas suicidaires

Le 21 janvier 2022 à 11:12:33 :
Malheureusement ca va rien changer

C'est le BMJ qui demande officiellement les data, c'est énorme khey

Le 21 janvier 2022 à 11:13:43 :
Et pendant ce temps là la team Macron force pour installer le pass vaccinal.

Le conseil scientifique a demandé à la presse d’arrêter de donner la parole aux gens qui doutent du vaccin

Le 21 janvier 2022 à 11:13:43 :
Et pendant ce temps là la team Macron force pour installer le pass vaccinal.

Ils ont quand même eu l'honnêteté de demander une commission d'enquête dont personne de doute du résultat

Le 21 janvier 2022 à 11:12:48 :
Pour Raoult ça a engagé une armée de debunkers (alors qu’au final que l’HCQ marche ou pas osef complet), pour Pfizer que dalle

L'hydoxichloroquine marche en plus de ça, c'est vraiment qu'on veut notre mal si on nous empêche de nous soigner pour vouloir nous faire prendre des vaccins douteux

Lien PDF du topax : https://docdro.id/nU6Peip

Le 21 janvier 2022 à 11:14:49 :
Comme d'habitude y aura rien + c'est très facile pour Pfizer de falsifier les données donc même s'ils les donnent rien ne prouvera que ces données soient vraies.

Des donnés falsifiées ça se voit comme dans l'étude du Lancet, c'est peut-être pour ça que Pfizer veut pas les donner issou